Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alexander S. Rosemurgy
A Systematic Review of Neoadjuvant Therapy Compared to the “Resection First” Approach for Patients With Borderline Resectable Pancreatic Adenocarcinoma
Journal of Cancer Therapy
Related publications
Increased Neutrophil-To-Lymphocyte Ratio After Neoadjuvant Therapy Is Associated With Worse Survival After Resection of Borderline Resectable Pancreatic Ductal Adenocarcinoma
Surgery
Surgery
Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
Journal of Clinical Medicine
An Evaluation of Neoadjuvant Chemoradiotherapy for Patients With Resectable Pancreatic Ductal Adenocarcinoma
HPB Surgery
Surgery
Hepatology
Folfirinox Neoadjuvant Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer - A Retrospective Study
International Journal of Contemporary Medical Research [IJCMR]
Meta-Analysis Comparing Upfront Surgery With Neoadjuvant Treatment in Patients With Resectable or Borderline Resectable Pancreatic Cancer
British Journal of Surgery
Surgery
A Pilot Study- Neoadjuvant Chemotherapy With Gemcitabine and S1 in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Journal of Carcinogenesis & Mutagenesis
Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis
Oncologist
Cancer Research
Medicine
Oncology
Preoperative Nomogram to Predict Survival for Patients With Resectable and Borderline Resectable Pancreatic Cancer
HPB
Hepatology
Gastroenterology
Neoadjuvant Imatinib for Borderline Resectable GIST
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
